Description
⋅ Inverse H&S / C&H Formation: Yearly Basis
C&H Price Trendline BreakOut
Vol. Consolidation/BreakOut
*With Upside, Trail SL*
*Book Profit as per Risk Appetite*
*Snapshot*
Estab. in 1987, engaged in manufacturing of APIs
Revenue /Profit Stable on Qtrly/Yrly Basis. Gaining Traction.
Moderate Leverage Growing TNW. Profits Retained
CF for Ops. Increasingly +ve
Improved RoA/RoE/RoCE for FY22.
Promoters Stake Up Since Mar’22 / DII Stake Stable
*Concern:*
High Revenue Dependence on Ciprofloxacin API
High Public Stake at 42.58%
*Do Your Own Research as Well. This is Just an Opinion.*
Happy Investing :)